N,N-Dialkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, potent, selective δ opioid agonists
Compounds such as 15a and 15c are potent and selective δ opioid agonists.
References (24)
- et al.
Eur. J. Pharmacol.
(1995) - et al.
Bioorg. Med. Chem. Lett.
(2000) - et al.
Bioorg. Med. Chem. Lett.
(2000) - et al.
Int. Immunopharmacol.
(2001) - et al.
Bioorg. Med. Chem. Lett.
(1999) - et al.
J. Pharmacol. Exp. Ther.
(1976) - et al.
J. Pharmacol. Exp. Ther.
(1984) - et al.
J. Pharmacol. Exp. Ther.
(1993) - et al.
J. Med. Chem.
(1994) - et al.
J. Pharmacol. Exp. Ther.
(1995)
Analgesia
(1998)
Exp. Opin. Ther. Pat.
(1997)
Cited by (24)
Palladium(II)/2,2′-bipyridine-catalyzed addition of arylboronic acids to N-tosyl-arylaldimines
2009, Tetrahedron LettersBis(2-thienyl)silanes: new, versatile precursors to arylsilanediols
2006, Tetrahedron Letters4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective δ-opioid agonists
2006, Bioorganic and Medicinal Chemistry LettersEndogenous opiates and behavior: 2004
2005, PeptidesCitation Excerpt :{+}-4, was created from the 5-phenylmorphan class of opioids [176]. Compound 15a and 15c of an N-alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)-phenylmethyl]-benzamide acted as a selective delta receptor agonist [178]. Menk absorption into the human nasal epithelium was markedly increased by protease inhibitors and absorption enhancers [7].
Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists
2004, Bioorganic and Medicinal Chemistry LettersN-Alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, μ and δ opioid agonists: A μ address
2004, Bioorganic and Medicinal Chemistry Letters
- 1
Present address: Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA.
Copyright © 2004 Elsevier Ltd. All rights reserved.